Abingworth related stories
All articles and analysis
Abingworth hires refinancing specialistFormer Bioscience Managers director Michelle Doig has been hired by Abingworth Management to advise the firm on funding and refinancing its portfolio companies.
- Abingworth hires biotech entrepreneurs
The UK life sciences investor has appointed two London-based entrepreneurs-in-residence to assist with portfolio companies and identify new investment targets.
- Abingworth closes Fund IV at $350m
The Anglo-American life sciences VC firm has exceeded the original $275m target for their Abingworth Bioventures IV fund (ABV IV), which was more than two times over-susbscribed.
- Deal round-up 07/04/03
Sovereign leads Principal Schools buyout; Epigenomics lands E21m third round; Apax backs E10m Corvil Networks round; Granville Baird backs German MBO; Granville Baird backs German MBO
- Deal round-up 08/05/03
Trinity backs E11.5m AePONA round; German VCs buy into semiconductor business; Viventures in broadband access investment; DVC backs Epigenomics third round; Nordic firms back Bone Support
- Galapagos completes E21m private placing
Abingworth, Apax and Burrill are co-leaders in the first round funding for the Belgian/Dutch genomics company.
- Abingworth closes biotech fund
At $225m, Bioventures III LP closed $75m over its initial target, said the UK-based venture capitalist.
- Danish drug developer takes E15.2m injection
BioImage has secured E15.2m second round funding from a consortium of investors led by Abingworth Management.
- Deal Round-up 20/12/01
Xantos takes E21m funding; AMJPE invests £550,000 in security technology; T-Ventures invests in Boden subsidiary; UK’s Astex secures £5.7m funding;